ChemoCentryx
CCXI
#3654
Rank
โ‚น349.49 B
Marketcap
โ‚น4,860
Share price
0.00%
Change (1 day)
41.01%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -โ‚น143.43

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -โ‚น176.66. In 2021 the company made an earnings per share (EPS) of -โ‚น176.66 a decrease over its 2020 EPS that were of -โ‚น75.71.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-โ‚น143.43-18.81%
2021-โ‚น176.66133.33%
2020-โ‚น75.71-16.49%
2019-โ‚น90.6727.63%
2018-โ‚น71.04-305.41%
2017โ‚น34.58-142.53%
2016-โ‚น81.32-19.44%
2015-โ‚น100.95-0%
2014-โ‚น100.9513.68%
2013-โ‚น88.80-16.67%
2012-โ‚น106.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น624.36-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น66.36-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น546.95-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,625-1,019.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น220.59-224.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.82-152.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น422.48-339.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น268.95-252.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น42.06-123.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel